Answers are grounded in this paper and cite their sources.
In the prevention and treatment of thromboembolic disease, novel oral anticoagulants have emerged as alternatives to warfarin. A major challenge continues to be the reversal of their anticoagulant effect in the case of life-threatening haemorrhagic complications. We report a case of spontaneous splenic rupture treated by splenic artery embolisation in a 77-year-old woman who was anticoagulated with rivaroxaban.
No takes yet. Share an insight, caveat, or question.
Nagaraja et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: